Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sihuan Pharma Sells 50% of Drug Distribution Subsidiary to Shandong Buchang

publication date: Jul 19, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sihuan Pharmaceutical Holdings will sell a 50% stake in a drug distribution subsidiary to Shandong Buchang Pharmaceutical at a price of 637.5 million RMB ($98.6 million). Both companies have expertise in the cardio-cerebral vascular sector. It was a good deal for Sihuan, which purchased the assets last month for 775 million RMB ($120 million). More details....

Stock Symbol: (HK: 0640)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...